B. Metzler seel. Sohn & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Hold |
3,233
| – | – | 0.01% | 531 |
|
|
2025
Q1 | $873K | Sell |
3,233
-46
| -1% | -$12.4K | 0.01% | 549 |
|
|
2024
Q4 | $772K | Hold |
3,279
| – | – | 0.01% | 582 |
|
|
2024
Q3 | $902K | Sell |
3,279
-738
| -18% | -$203K | 0.01% | 566 |
|
|
2024
Q2 | $976K | Buy |
4,017
+99
| +3% | +$24.1K | 0.01% | 528 |
|
|
2024
Q1 | $586K | Buy |
3,918
+190
| +5% | +$28.4K | 0.01% | 599 |
|
|
2023
Q4 | $714K | Hold |
3,728
| – | – | 0.01% | 554 |
|
|
2023
Q3 | $660K | Buy |
3,728
+37
| +1% | +$6.55K | 0.01% | 541 |
|
|
2023
Q2 | $701K | Hold |
3,691
| – | – | 0.01% | 537 |
|
|
2023
Q1 | $739K | Buy |
3,691
+367
| +11% | +$73.5K | 0.01% | 491 |
|
|
2022
Q4 | $790K | Buy |
3,324
+1,005
| +43% | +$239K | 0.01% | 470 |
|
|
2022
Q3 | $464K | Hold |
2,319
| – | – | 0.01% | 553 |
|
|
2022
Q2 | $338K | Hold |
2,319
| – | – | 0.01% | 623 |
|
|
2022
Q1 | $379K | Hold |
2,319
| – | – | 0.01% | 650 |
|
|
2021
Q4 | $397K | Buy |
2,319
+374
| +19% | +$64K | 0.01% | 603 |
|
|
2021
Q3 | $367K | Hold |
1,945
| – | – | 0.01% | 608 |
|
|
2021
Q2 | $330K | Buy |
1,945
+468
| +32% | +$79.4K | ﹤0.01% | 606 |
|
|
2021
Q1 | $209K | Buy |
+1,477
| New | +$209K | ﹤0.01% | 659 |
|